Logotype for KORU Medical Systems Inc

KORU Medical Systems (KRMD) Registration filing summary

Event summary combining transcript, slides, and related documents.

Logotype for KORU Medical Systems Inc

Registration filing summary

16 Nov, 2026

Company overview and business model

  • Develops, manufactures and commercializes large-volume subcutaneous infusion solutions for drug delivery, subject to FDA quality and regulatory requirements and international quality standards.

  • FREEDOM System includes FREEDOM60 and FreedomEdge syringe infusion drivers, Precision Flow Rate Tubing and HIgH-Flo safety needle sets for home and alternate-care infusions.

Use of proceeds and capital allocation

  • Net proceeds will be allocated as specified in each prospectus supplement; potential uses include acquisitions, debt repayment or refinancing, working capital and capital expenditures.

  • No cash dividends are planned in the foreseeable future; available funds are intended for operations, and the KeyBank credit facility restricts cash dividends and distributions.

Risk factors and disclosures

  • Identified risks include competition, insurance reimbursement, FDA and international regulation, healthcare policy, R&D outcomes, product demand and market acceptance, technology changes, quality and approvals.

  • Additional exposures include capital access, credit-facility covenants, patents, cybersecurity, supplier performance, distributor preference, key-personnel retention, litigation, tax and labor laws, trade policy and economic conditions.

  • Forward-looking statements reflect estimates and assumptions as of November 13, 2026; actual results may differ materially, and updates are not undertaken except as required by law.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from KORU Medical Systems